•
Mar 31, 2020

Chemed Q1 2020 Earnings Report

Chemed's first quarter results for 2020 were reported, demonstrating revenue growth and increased earnings per share.

Key Takeaways

Chemed Corporation reported an 11.6% increase in revenue to $516 million for the first quarter of 2020. GAAP diluted EPS increased by 25.2% to $3.38, and adjusted diluted EPS increased by 26.0% to $3.68.

Consolidated revenue increased by 11.6% to $516 million.

GAAP diluted EPS increased by 25.2% to $3.38.

VITAS net patient revenue increased by 10.1% to $338 million.

Roto-Rooter revenue increased by 14.6% to $178 million.

Total Revenue
$516M
Previous year: $462M
+11.6%
EPS
$3.68
Previous year: $2.92
+26.0%
Admissions
18.6K
Previous year: 17.76K
+4.8%
Average Daily Census
19.22K
Previous year: 18.35K
+4.7%
Gross Profit
$164M
Previous year: $140M
+17.1%
Cash and Equivalents
$29M
Previous year: $8.77M
+230.7%
Free Cash Flow
$69.4M
Previous year: $59.7M
+16.3%
Total Assets
$1.28B
Previous year: $1.07B
+19.4%

Chemed

Chemed

Chemed Revenue by Segment

Forward Guidance

Management anticipates providing updated 2020 earnings guidance in July 2020 as part of the June 30, 2020, earnings press release.

Revenue & Expenses

Visualization of income flow from segment revenue to net income